Published in Lancet on July 01, 2000
Impact of CVVHD With Increased Adsorption Membranes in Septic Acute Kidney Injury | NCT01790620
Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol (2008) 2.84
Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care (2007) 2.31
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care (2009) 2.03
Intermittent high-volume predilution on-line haemofiltration versus standard intermittent haemodialysis in critically ill patients with acute kidney injury: a prospective randomized study. Nephrol Dial Transplant (2012) 2.02
Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol (2007) 1.82
The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int (2014) 1.80
Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials (2005) 1.75
Acid-base status of critically ill patients with acute renal failure: analysis based on Stewart-Figge methodology. Crit Care (2003) 1.64
Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol (2004) 1.60
Dosing of renal replacement therapy in acute kidney injury. Am J Kidney Dis (2012) 1.49
Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care (2011) 1.47
Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transplant (2011) 1.46
Renal replacement therapy for acute renal failure in children: European guidelines. Pediatr Nephrol (2003) 1.35
Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol (2008) 1.25
Clinical review: extracorporeal blood purification in severe sepsis. Crit Care (2003) 1.23
Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care (2008) 1.22
Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol (2010) 1.20
Volume-related weight gain and subsequent mortality in acute renal failure patients treated with continuous renal replacement therapy. ASAIO J (2010) 1.19
Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care (2011) 1.13
Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care (2015) 1.12
In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care (2005) 1.12
Continuous renal replacement therapy in children. Pediatr Nephrol (2012) 1.10
Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care (2005) 1.08
Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2010) 1.07
High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care (2014) 1.07
The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care (2014) 1.06
Pathophysiology and management of septic acute kidney injury. Pediatr Nephrol (2013) 1.05
Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol (2010) 1.03
Evidence-based medicine: classifying the evidence from clinical trials--the need to consider other dimensions. Crit Care (2006) 1.02
Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care (2009) 1.01
Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study. Crit Care (2006) 1.00
Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care (2011) 1.00
Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant (2009) 0.99
The Japanese guidelines for the management of sepsis. J Intensive Care (2014) 0.99
Dialysis dose in acute kidney injury: no time for therapeutic nihilism--a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care (2008) 0.98
N-GAL: diagnosing AKI as soon as possible. Crit Care (2007) 0.97
Prognosis in critically ill children requiring continuous renal replacement therapy. Pediatr Nephrol (2005) 0.97
Sepsis-associated acute kidney injury. Semin Nephrol (2015) 0.96
Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study. Crit Care (2014) 0.96
Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study. PLoS One (2015) 0.96
Renal replacement therapy in acute kidney injury. Adv Chronic Kidney Dis (2013) 0.95
Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study. Crit Care (2009) 0.94
Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care (2006) 0.93
Clinical review: timing and dose of continuous renal replacement therapy in acute kidney injury. Crit Care (2007) 0.92
Clinical review: timing of renal replacement therapy. Crit Care (2011) 0.92
Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol (2009) 0.92
Mechanical ventilation and the kidney. Blood Purif (2009) 0.91
Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care (2005) 0.90
Perioperative acute kidney injury. Perioper Med (Lond) (2012) 0.90
Circuit lifespan during continuous renal replacement therapy: children and adults are not equal. Crit Care (2008) 0.90
Acute renal replacement therapy in pediatrics. Int J Nephrol (2011) 0.89
Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol (2009) 0.89
Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes. Clin J Am Soc Nephrol (2015) 0.88
Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care (2003) 0.88
Renal replacement therapy review: past, present and future. Organogenesis (2011) 0.88
Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock? Crit Care (2002) 0.87
Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol (2005) 0.87
Sepsis-induced acute kidney injury. Indian J Crit Care Med (2010) 0.86
A retrospective review of the use of regional citrate anticoagulation in continuous venovenous hemofiltration for critically ill patients. Crit Care Res Pract (2013) 0.86
Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration. Korean J Intern Med (2011) 0.86
Current therapeutic strategies for acute kidney injury. Clin Exp Nephrol (2012) 0.86
Renal cell therapy and beyond. Semin Dial (2009) 0.86
Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience. Nephrourol Mon (2013) 0.85
Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population. Surg Today (2014) 0.85
Promoting Kidney Function Recovery in Patients with AKI Requiring RRT. Clin J Am Soc Nephrol (2015) 0.85
Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study. Crit Care (2007) 0.84
Circulating pro-apoptotic mediators in burn septic acute renal failure. Crit Care (2008) 0.84
Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations. Antimicrob Agents Chemother (2012) 0.84
Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary data. Biomed Res Int (2013) 0.84
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Crit Care (2014) 0.84
Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration. Antimicrob Agents Chemother (2011) 0.83
Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol (2014) 0.83
Renal replacement therapy in the intensive care unit. Ther Clin Risk Manag (2005) 0.83
Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI). Crit Care (2005) 0.83
Update on the diagnosis and management of acute kidney injury. Int J Nephrol Renovasc Dis (2010) 0.83
Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy. BMC Anesthesiol (2014) 0.83
Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment. Clin J Am Soc Nephrol (2013) 0.82
Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol (2016) 0.82
Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care (2002) 0.82
Biology of sepsis: its relevance to pediatric nephrology. Pediatr Nephrol (2014) 0.82
Antimicrobial dosing in acute renal replacement. Adv Chronic Kidney Dis (2013) 0.81
Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies. Crit Care (2016) 0.81
Clinical course of children requiring prolonged continuous renal replacement therapy. Pediatr Nephrol (2009) 0.80
Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome. World J Emerg Med (2012) 0.80
The need to reform our assessment of evidence from clinical trials: a commentary. Philos Ethics Humanit Med (2008) 0.80
Toward the optimal dose metric in continuous renal replacement therapy. Int J Artif Organs (2012) 0.80
The efficacy of activated protein C for the treatment of sepsis: incorporating observational evidence with a Bayesian approach. BMJ Open (2015) 0.80
Challenges and pitfalls when implementing renal replacement therapy in the ICU. Crit Care (2015) 0.79
The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care (2014) 0.79
Recent evolution of renal replacement therapy in the critically ill patient. Crit Care (2006) 0.79
Section 5: Dialysis Interventions for Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.79
Effluent volume and dialysis dose in CRRT: time for reappraisal. Nat Rev Nephrol (2011) 0.78
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med (2015) 4.95
Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med (2001) 4.07
Public reporting of surgical mortality: a survey of New York State cardiothoracic surgeons. Ann Thorac Surg (1999) 3.00
Mechanism of grass-pollen-induced asthma. Lancet (1992) 2.92
Quantitative physical chemistry analysis of acid-base disorders in critically ill patients. Anaesthesia (2001) 2.70
Cranberry juice and urinary tract infection. Clin Infect Dis (2004) 2.68
Acute renal failure: time for consensus. Intensive Care Med (2001) 2.53
Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg (2001) 2.40
Results of the Scoliosis Research Society instrument for evaluation of surgical outcome in adolescent idiopathic scoliosis. A multicenter study of 244 patients. Spine (Phila Pa 1976) (1999) 2.21
Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med (2001) 2.17
Transanal haemorrhoidal artery echodoppler ligation and anopexy (THD) is effective for II and III degree haemorrhoids: a prospective multicentric study. Colorectal Dis (2010) 2.11
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
The effects of plasmalyte-148 vs. Hartmann's solution during major liver resection: a multicentre, double-blind, randomized controlled trial. Minerva Anestesiol (2014) 2.01
Campylobacter pylori infection in uremic dialyzed patients. Eradication of the infection by colloidal bismuth subcitrate. Nephron (1990) 2.00
Renal blood flow in experimental septic acute renal failure. Kidney Int (2006) 1.83
Myocardial cell injury in septic shock. Crit Care Med (1999) 1.82
Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs (2007) 1.73
Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiol (2010) 1.73
Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med (2010) 1.68
Release of lactate by the lung in acute lung injury. Chest (1997) 1.66
Morbidity and mortality in elderly trauma patients. J Trauma (1999) 1.64
A wearable hemofilter for continuous ambulatory ultrafiltration. Kidney Int (2007) 1.59
Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis (2002) 1.59
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth (2014) 1.57
A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int (1991) 1.57
Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis (1996) 1.54
High-volume haemofiltration in human septic shock. Intensive Care Med (2001) 1.52
Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia (1999) 1.50
Current oxygenation practice in ventilated patients-an observational cohort study. Anaesth Intensive Care (2013) 1.45
Accurate prediction of the amount of in situ tumor in palpable breast cancers by core needle biopsy: implications for neoadjuvant therapy. Ann Surg Oncol (1999) 1.44
The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc (2002) 1.43
Postoperative hypothermia and patient outcomes after elective cardiac surgery. Anaesthesia (2011) 1.43
Studies in thoracic aortic graft infections: the development of a porcine model and a comparison of collagen-impregnated dacron grafts and cryopreserved allografts. J Thorac Cardiovasc Surg (1999) 1.43
Oxygen consumption and lactate release by the lung after cardiopulmonary bypass and during septic shock. Crit Care Resusc (2000) 1.42
Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med (1999) 1.42
Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients. Am J Hematol (1993) 1.40
Successful emergency percutaneous balloon mitral valvotomy in a patient with massive left atrial thrombosis: utility of transesophageal echocardiographic monitoring. Cardiology (1991) 1.39
Optic neuritis complicating west nile virus meningitis in a young adult. Infection (2003) 1.39
Plasma acid-base changes in chronic renal failure: a Stewart analysis. Int J Artif Organs (2005) 1.39
Comments on Efendijev et al.: temporal trends in cardiac arrest incidence and outcome in Finnish intensive care units from 2003 to 2013. Intensive Care Med (2015) 1.38
Effect of perfusion pressure on the splanchnic circulation after CPB: a pilot study. Minerva Anestesiol (2014) 1.37
RNA transport in dendrites: a cis-acting targeting element is contained within neuronal BC1 RNA. J Neurosci (1997) 1.35
Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol (2000) 1.33
Defining death in non-heart beating organ donors. J Med Ethics (2003) 1.32
Endocarditis caused by Staphylococcus warneri on a normal aortic valve following vasectomy. Can Med Assoc J (1984) 1.31
Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int (1996) 1.30
Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation (1998) 1.26
Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock (1998) 1.25
Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care (2002) 1.23
Septicemia caused by the gram-negative bacterium CDC IV c-2 in an immunocompromised human. J Clin Microbiol (1986) 1.22
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci U S A (1998) 1.22
A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med (2000) 1.18
The aetiology and pathogenesis of cardiopulmonary bypass-associated metabolic acidosis using polygeline pump prime. Intensive Care Med (1999) 1.17
Isolation of Mycoplasma hominis from the blood of men with multiple trauma and fever. JAMA (1982) 1.15
Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer. Oncologist (2001) 1.15
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med (1991) 1.15
Estimating unmeasured anions in critically ill patients: anion-gap, base-deficit, and strong-ion-gap. Anaesthesia (2002) 1.14
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol (1997) 1.14
An increased familial frequency of gallstones. Gastroenterology (1983) 1.13
Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron (1993) 1.12
The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. Int J Artif Organs (2008) 1.11
Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous venovenous hemofiltration/hemodiafiltration. Intensive Care Med (1997) 1.10
The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs (2005) 1.09
The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.08
Failure of continuous cardiac output measurement using the PiCCO Device during induced hypothermia: a case report. Crit Care Resusc (2004) 1.08
Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care (2005) 1.08
Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs (2001) 1.07
Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol (1999) 1.07
Goniometric assessment of shoulder range of motion: comparison of testing in supine and sitting positions. Arch Phys Med Rehabil (1998) 1.07
Strong ions, weak acids and base excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth (2004) 1.07
Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis (2001) 1.05
Hepatic anion flux during acute endotoxemia. J Appl Physiol (1985) (1995) 1.05
Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol (1998) 1.05
Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int (2000) 1.05
Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med (2000) 1.05
Acute Dialysis Quality Initiative (ADQI): methodology. Int J Artif Organs (2008) 1.04
Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord (2002) 1.04
Nurses' attitudes to a medical emergency team service in a teaching hospital. Qual Saf Health Care (2006) 1.04
Impact of continuous veno-venous hemofiltration on acid-base balance. Int J Artif Organs (2003) 1.03
What happens after discharge? Return hospital visits after ambulatory surgery. Anesth Analg (1997) 1.02
Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans. Clin Infect Dis (1994) 1.00
A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int (1992) 0.99
Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J Virol (2004) 0.99
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Clin Cancer Res (2000) 0.98
Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat (2006) 0.98
Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol (1999) 0.98
The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care (2005) 0.98
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. Int Immunol (1996) 0.98
The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs (2004) 0.98
Concentration of ciprofloxacin in human prostatic tissue after oral administration. Antimicrob Agents Chemother (1986) 0.97
Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant (2001) 0.97
Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med (2002) 0.96
In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis. J Exp Med (1990) 0.96
Predictors of physician confidence to diagnose pneumonia and determine illness severity in ventilated patients. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care (2005) 0.96
Pyogenic sacroiliitis in pregnancy. Int J Gynaecol Obstet (1999) 0.96
Oscillating growth patterns of multicellular tumour spheroids. Cell Prolif (1999) 0.96
Intensivists' opinion and self-reported practice of oxygen therapy. Anaesth Intensive Care (2011) 0.96
A case of lymphogranuloma venereum of 20 years' duration. Isolation of Chlamydia trachomatis from perianal lesions. Br J Vener Dis (1980) 0.95